Vicarious Surgical Inc. (NYSE: RBOT) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on March 3, 2026, it ...

Vicarious Surgical (NYSE:RBOT) announced today that the NYSE has commenced the process of delisting its stock. The Waltham, Massachusetts–based surgical robot developer received a notice from the ...

The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Vicarious Surgical ...

Vicarious Surgical Inc (NASDAQ:RBOT) shares are trading lower by 20% to $0.29 during Tuesday’s session after the company announced a 1-for-30 reverse stock split of its Class A and Class B common ...

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

The average one-year price target for Vicarious Surgical (NYSE:RBOT) has been revised to $5.10 / share. This is a decrease of 44.44% from the prior estimate of $9.18 dated December 3, 2025. The price ...

WALTHAM, Mass., March 03, 2025--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by ...